Table 10.

Exacerbation in Moderate and Severe Patients

Exacerbation
	Unadjusted		Adjusted *
Treatment	OR (95% CI)	P	OR (95% CI)	P
MP1 vs DEX1	1.062(0.675~1.674)	0.794	1.101(0.694~1.746)	0.683
MP2 vs Con	0.435(0.202~0.940)	0.034	0.179(0.071~0.452)	0.001
DEX2 vs Con	0.452(0.220~0.931)	0.031	0.237(0.014~0.539)	0.001
MP2 vs DEX2	0.962(0.392~2.361)	0.933	0.614(0.209~1.801)	0.374
MP2 vs MP3	0.315(0.129~0.771)	0.011	0.301(0.114~0.795)	0.015

Note: * Adjusted by age, and clinical lab index including CRP, LDH, and absolute lymphocyte. Bold font indicates statistically significant values (p < 0.05).

Abbreviations: MP¹, methylprednisolone 40 mg/day group in severe patients; MP², methylprednisolone 40 mg/day group in moderate patients; MP³, methylprednisolone 20 mg/day group in moderate patients; DEX¹, dexamethasone 5 mg/day group in severe patients; DEX², dexamethasone 5 mg/day group in severe patients; Con, no-use glucocorticoid group; OR, Odds ratio; CI, Confidence interval.